Xinnate to raise an additional SEK 100 million
29 January 2024
29 January 2024
Total investments received (USD): 12.99m
Round value (USD): 9.7m
Company: Xinnate
Related deals
Rarity Bioscience in a a €6.5 million funding round led by Navigare Ventures, joined by existing shareholders Novalis Biotech and UU Invest
Investments
09 June 2024
Symcel raised SEK 86 million with Lareim AB and Flerie Invest AB.
Investments
09 March 2024
Cellcolabs raised $8.7 million from private investors in Sweden.
Investments
14 February 2024
Pixelgen in a $7.3 million series A round co-led by Industrifonden and Navigare Ventures.
Investments
05 October 2023
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom